Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista de la Facultad de Medicina
versión impresa ISSN 0120-0011
Resumen
ESPINOSA-ALMANZA, Carmelo José y GAITAN-DUARTE, Hernando. Chronic kidney disease and bleeding in patients under low molecular weight heparin prophylaxis. rev.fac.med. [online]. 2017, vol.65, n.4, pp.627-631. ISSN 0120-0011. https://doi.org/10.15446/revfacmed.v65n4.59769.
Introduction:
The safety of low molecular weight heparin (LMWH) prophylaxis in patients with impaired kidney function remains undefined.
Objective:
To establish if the reduction of the glomerular filtration rate (GFR) is associated with the development of bleeding under LMWH prophylaxis.
Materials and methods:
A cohort of non-surgical patients with LMWH prophylaxis was constructed in order to conduct a case-control study. Monitoring allowed to find bleeding cases, while four controls were chosen from the population at risk at the time of bleeding onset.
Results:
Out of 716 monitored patients, 51 presented with bleeding, with an incidence of 3 cases per 100 patients per day of treatment; 39% of the cases presented with major bleeding and 204 controls were chosen. The multivariate analysis showed no relationship between bleeding and abnormal renal function due to GFR reduction. However, only 3.5% ofpatients had GFR <30ml/min. The final adjusted odds ratio (OR) was 1.27 and the 95% confidence interval (CI) was 0.60-2.68.
Conclusion:
No correlation was found between the reduction of mild to moderate GFR and the development of bleeding under LMWH prophylaxis.
Palabras clave : Deep Venous Thrombosis; Enoxaparin; Pulmonary Embolism (MeSH).